These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23299228)

  • 1. Conflating the approval process and clinical research with pharmacoeconomic evaluation.
    Somberg JC
    Am J Ther; 2013 Jan; 20(1):1. PubMed ID: 23299228
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative assessment for medications and devices: apples and oranges?
    Ramsey S
    Value Health; 2010 Jun; 13 Suppl 1():S12-4. PubMed ID: 20618788
    [No Abstract]   [Full Text] [Related]  

  • 3. Dermatology clinical trials and drug development.
    Ehrenberger HE; Joshi TG
    Dermatol Nurs; 2003 Oct; 15(5):428-34. PubMed ID: 14619320
    [No Abstract]   [Full Text] [Related]  

  • 4. NINDS common data element project: a long-awaited breakthrough in streamlining trials.
    Stone K
    Ann Neurol; 2010 Jul; 68(1):A11-3. PubMed ID: 20583225
    [No Abstract]   [Full Text] [Related]  

  • 5. [The relevance of head-to-head trials to patient-centred clinical research].
    Lehmacher W; Wolff S
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(9):639-45. PubMed ID: 22152420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying quality leads - an important factor in reducing attrition of clinical candidates.
    Chackalamannil S; Desai MC
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):381-2. PubMed ID: 17659478
    [No Abstract]   [Full Text] [Related]  

  • 7. A proposal for radical changes in the drug-approval process.
    Wood AJ
    N Engl J Med; 2006 Aug; 355(6):618-23. PubMed ID: 16899784
    [No Abstract]   [Full Text] [Related]  

  • 8. The role and impact of research agendas on the comparative-effectiveness research among antihyperlipidemics.
    Dunn AG; Bourgeois FT; Murthy S; Mandl KD; Day RO; Coiera E
    Clin Pharmacol Ther; 2012 Apr; 91(4):685-91. PubMed ID: 22378152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From molecule to medicine--drug development].
    Bruhn C
    Dtsch Med Wochenschr; 2010 Feb; 135(6):p5. PubMed ID: 20151355
    [No Abstract]   [Full Text] [Related]  

  • 10. [Closing evidence gaps].
    Lange S
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(9):652-6. PubMed ID: 22152422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Con: comparative effectiveness research. More than dollars and cents.
    Krishnan JA
    Am J Respir Crit Care Med; 2011 Apr; 183(8):975-6. PubMed ID: 21498823
    [No Abstract]   [Full Text] [Related]  

  • 12. Building comparative efficacy and tolerability into the FDA approval process.
    O'Connor AB
    JAMA; 2010 Mar; 303(10):979-80. PubMed ID: 20215612
    [No Abstract]   [Full Text] [Related]  

  • 13. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J
    New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
    [No Abstract]   [Full Text] [Related]  

  • 14. Dosing strategies for antidepressant clinical trials: a commentary.
    Robinson DS; Khan A
    J Clin Psychopharmacol; 2004 Feb; 24(1):1-3. PubMed ID: 14709939
    [No Abstract]   [Full Text] [Related]  

  • 15. [Electronic medical record in clinical trials of effectiveness of drugs integrated in clinical practice].
    Carcas AJ; Abad Santos F; Sánchez Perruca L; Dal-Ré R
    Med Clin (Barc); 2015 Nov; 145(10):452-7. PubMed ID: 25913907
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative effectiveness research in spine surgery.
    Abdullah KG; Benzel EC; Mroz TE
    Neurosurg Focus; 2012 Jul; 33(1):E2. PubMed ID: 22746234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposed new clinical trial system at NCI gets mixed reviews.
    Nicholas J
    J Natl Cancer Inst; 2011 Feb; 103(4):292-5. PubMed ID: 21303997
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development.
    Schneeweiss S; Gagne JJ; Glynn RJ; Ruhl M; Rassen JA
    Clin Pharmacol Ther; 2011 Dec; 90(6):777-90. PubMed ID: 22048230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Note on special technical issue on adaptive designs for clinical trials.
    Liu Q; Chang M
    J Biopharm Stat; 2012; 22(4):615-6. PubMed ID: 22651104
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug safety sciences and the bottleneck in drug development.
    Watkins PB
    Clin Pharmacol Ther; 2011 Jun; 89(6):788-90. PubMed ID: 21593756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.